GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $533,000 | -3.8% | 36,490 | -6.4% | 0.20% | -28.4% |
Q3 2020 | $554,000 | -3.5% | 38,990 | 0.0% | 0.28% | -10.3% |
Q2 2020 | $574,000 | +256.5% | 38,990 | 0.0% | 0.31% | +181.8% |
Q1 2020 | $161,000 | +847.1% | 38,990 | +997.1% | 0.11% | +1275.0% |
Q4 2019 | $17,000 | -22.7% | 3,554 | 0.0% | 0.01% | -27.3% |
Q3 2019 | $22,000 | -4.3% | 3,554 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $23,000 | -8.0% | 3,554 | 0.0% | 0.01% | -15.4% |
Q1 2019 | $25,000 | +47.1% | 3,554 | 0.0% | 0.01% | +30.0% |
Q4 2018 | $17,000 | -41.4% | 3,554 | -11.2% | 0.01% | -33.3% |
Q3 2018 | $29,000 | 0.0% | 4,004 | -11.3% | 0.02% | -11.8% |
Q2 2018 | $29,000 | +16.0% | 4,514 | 0.0% | 0.02% | -37.0% |
Q1 2018 | $25,000 | +66.7% | 4,514 | +27.2% | 0.03% | +200.0% |
Q4 2017 | $15,000 | -55.9% | 3,550 | 0.0% | 0.01% | -57.1% |
Q3 2017 | $34,000 | -19.0% | 3,550 | 0.0% | 0.02% | -22.2% |
Q2 2017 | $42,000 | -8.7% | 3,550 | 0.0% | 0.03% | -10.0% |
Q1 2017 | $46,000 | +7.0% | 3,550 | 0.0% | 0.03% | 0.0% |
Q4 2016 | $43,000 | +2.4% | 3,550 | 0.0% | 0.03% | 0.0% |
Q3 2016 | $42,000 | +35.5% | 3,550 | 0.0% | 0.03% | +30.4% |
Q2 2016 | $31,000 | +55.0% | 3,550 | -7.3% | 0.02% | +53.3% |
Q1 2016 | $20,000 | -33.3% | 3,830 | 0.0% | 0.02% | 0.0% |
Q3 2015 | $30,000 | +7.1% | 3,830 | +23.2% | 0.02% | +15.4% |
Q2 2015 | $28,000 | -30.0% | 3,110 | 0.0% | 0.01% | -31.6% |
Q1 2015 | $40,000 | -21.6% | 3,110 | -17.3% | 0.02% | -32.1% |
Q4 2014 | $51,000 | – | 3,760 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|